About the IMS

The International Myeloma Society (IMS) is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners. IMS is governed by a Board of Directors representing practices from around the world and encourages and promotes the study of this expanding field through its annual International Myeloma Meeting.

About the Annual Meeting

The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects. This year’s program includes:

  • Six thematic sessions on:
    • Precursor Disease
    • Newly Diagnosed
    • High Risk Disease
    • Relapsed: Treatments Outside of Immunotherapy
    • Immunotherapy
    • Novel Biomarkers - personalizing therapy in myeloma
  • Talks and symposia on pressing topics led by the KOL of the myeloma community 
  • Special Sessions for trainees and local attendees 
  • Keynote addresses 
  • Joint sessions with regulatory agencies and other organisations 
  • Special sessions on MRD and New Endpoints
  • Oral Abstracts (on Basic Biology, Preclinical Trials, and Clinical Studies)
  • Poster Presentations

Riocentro, a world-class meeting venue, situated in the heart of Rio de Janeiro, is easily accessible from the city center and major transportation hubs. This central location makes it convenient for attendees traveling from different parts of the city and internationally. The self-contained campus is secure and environmentally friendly.  The IMS Annual Meeting will occupy the entire conference center inside the Riocentro campus creating an insulated and intimate environment for non-stop learning.

21st International Myeloma Society Annual Meeting
September 25-28, 2024 ~ Rio De Janeiro, Brazil